Table 3.
Factor | p | OR (95% CI) |
---|---|---|
Age at onset per 1 year | 0.142 | 0.907 (0.80–1.03) |
Female gender versus male | 0.993 | 1.009 (0.14–7.21) |
BMI at onset | 0.044 | 0.734 (0.54–0.99) |
Serum AQP4-antibody positive versus negative | 0.001 | 0.004 (0.00–0.12) |
Bilateral affected versus unilateral | 0.008 | 0.042 (0.00–0.43) |
logMAR VA at onset | 0.467 | 0.792 (0.42–1.48) |
Time window from onset to start of PE therapy per 1 day | 0.002 | 0.790 (0.68–0.91) |
Multivariate generalised estimating equation analyses with final visual acuity (VA) outcome (VA > 20/40 versus VA ⩽ 20/40) as dependent variable (working correlation matrix autoregressive of the first order; n = 55 eyes of 37 subjects).
Bold, p < 0.05.
CI, confidence interval; AQP4, aquaporin-4; BMI, body mass index; logMAR, log of the minimum angle of resolution; OR, odds ratio; PE, plasma exchange; VA, visual acuity.